Literature DB >> 6191007

Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I.

E Verjans, P Theys, P Delmotte, H Carton.   

Abstract

In a search for early prognostic features in multiple sclerosis, the progression rate was calculated in 200 consecutive multiple sclerosis patients who had had a lumbar puncture, and correlated with age at onset, type of disease course, the patient's sex, as well as with indices of blood-brain barrier breakdown and intrathecal IgG synthesis. The present study demonstrates that age at onset plays a role in determining whether the disease will be remitting-relapsing or chronic progressive. Age at onset is also a factor determining the rate of progression of the remitting-relapsing form, but is without influence on the progression of the chronic progressive form. A chronic progressive disease course per se (independent of age at onset) is also associated with a more rapid deterioration. The patient's sex does not appear to be a differentiating factor. Only inconsistent correlations were found between IgG index or number of oligoclonal bands in the CSF and disease progression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191007     DOI: 10.1007/bf00313739

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

Review 2.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Clinical factors determining prognosis in multiple sclerosis.

Authors:  U Leibowitz; M Alter
Journal:  Neurology       Date:  1968-03       Impact factor: 9.910

5.  Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis.

Authors:  O Christensen; J Clausen; T Fog
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

6.  Clinical picture of multiple sclerosis with late onset.

Authors:  C L Cazzullo; A Ghezzi; S Marforio; D Caputo
Journal:  Acta Neurol Scand       Date:  1978-09       Impact factor: 3.209

7.  Gel isoelectric focusing of cerebrospinal fluid proteins: a potential diagnostic tool.

Authors:  P Delmotte
Journal:  Z Klin Chem Klin Biochem       Date:  1971-07

8.  Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

Authors:  L Stendahl-Brodin; H Link
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

9.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

Authors:  C Confavreux; G Aimard; M Devic
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  The course of multiple sclerosis cases with extremely high gamma-globulin values in the cerebrospinal fluid.

Authors:  R Schmidt; H P Rieder; R Wüthrich
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

View more
  6 in total

1.  Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study.

Authors:  K Lauer; W Firnhaber
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Authors:  O Olerup; J Hillert; S Fredrikson; T Olsson; S Kam-Hansen; E Möller; B Carlsson; J Wallin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

Authors:  G V McDonnell; S A Hawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

Review 4.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

5.  Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.

Authors:  S A Hawkins; G V McDonnell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

6.  No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Authors:  Madlyne Becker; Clotilde Latarche; Emilie Roman; Marc Debouverie; Catherine Malaplate-Armand; Francis Guillemin
Journal:  BMC Neurol       Date:  2015-05-13       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.